Contents 2 min read
Claim and source comparison
5-HTP: depression research, an interaction case and plasma measurements.
· Bounded source comparison; not a complete clinical review or independent medical endorsement.
Systematic review / meta-analysis
In the Cochrane review, only 2 studies with 64 patients in total met the analysis criteria for 5-HTP and tryptophan.
The review considered two different substances together. This evidence cannot establish the effectiveness or long-term safety of 5-HTP alone for depression.
Source 2 · Abstract read
Human case report / case review
A 2017 case report described severe serotonin syndrome in a patient taking several products, including sertraline and 5-HTP.
Other exposures and uncertain doses limit causal interpretation. A single case cannot establish the frequency of an interaction or a safe dose.
Source 5 · Full text read
Human pharmacokinetic study
In a 1978 study of 5 participants, plasma half-life after a single oral dose was 2.2–3.0 hours. It was 5.5 hours in one participant during long-term carbidopa use.
These are plasma measurements under specific study conditions. They do not establish effect duration, repeat dosing or the safety of adding carbidopa.
Source 6 · Abstract read
Correction · 2026-11-11: Removed the generalized half-life. The plasma measurements, depression review and interaction case now have separate source links.
⚠ Critical Interaction Warning - Serotonin Syndrome
5-HTP should not be combined with serotonergic medicines; serotonin syndrome can be life-threatening. Adding carbidopa is not a safety solution and belongs only within physician-directed treatment. Long-term safety is uncertain.
What is 5-HTP?
5-HTP (5-Hydroxytryptophan) is a compound produced in the body from the essential amino acid tryptophan and is a direct intermediate step in the synthesis of serotonin (5-HT). Commercial supplements often Griffonia simplicifolia It is obtained from the seeds of the West African plant called.
Unlike tryptophan, 5-HTP bypasses the rate-limiting enzyme tryptophan hydroxylase and converts directly to serotonin after crossing the blood-brain barrier. For this reason, it is being investigated as a serotonin precursor that may have an effect on mood, sleep patterns and appetite.
Mechanism of Effect
5-HTP is a precursor converted to serotonin by AADC. Serotonin’s role in melatonin synthesis does not by itself show that 5-HTP supplements treat insomnia or correct a serotonin deficiency.
Clinical Evidence
In the Cochrane review by Shaw et al. (2002), only 2 trials totaling 64 patients met the inclusion criteria for 5-HTP and tryptophan. This small pooled dataset does not establish 5-HTP alone as a proven depression treatment; evidence on efficacy and safety was insufficient.
Dose information and research limits
A standard dose of 5-HTP with established safety and effectiveness for sleep or depression has not been determined.
Safety and Side Effects
Long-term safety of 5-HTP has not been adequately studied; a “reasonable dose” does not establish safety. Nausea and other digestive symptoms may occur. A possible link with eosinophilia-myalgia syndrome (EMS), including the role of impurities, remains unresolved; product testing cannot guarantee clinical safety. Combining it with serotonergic medicines can cause life-threatening serotonin syndrome.
Who Does It Interact With?
- SSRI/SNRI/antidepressants: DO NOT COMBINE - risk of serotonin syndrome
- MAO inhibitors: Contraindicated
- Triptans (migraine medications): Increased serotonergic load
- Tramadol, dextromethorphan: Serotonergic interaction
- Carbidopa: Reduces peripheral conversion; only under physician supervision
Related research and reading
These links show explicit editorial topic connections; they do not confirm a mechanism, efficacy or the safety of combined use. News dates refer to the source or event.
Educational guides
- Depression and Anxiety: Evidence and Risks of Natural Supplements
Evidence and drug interactions differ for saffron, St John’s wort, 5-HTP and other supplements; they are not treatments validated to the same extent.
Sources
- Birdsall TC. (1998). 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative Medicine Review, 3(4), 271–280. PubMed · PMID 9727088
- Shaw K, Turner J, Del Mar C. (2002). Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database of Systematic Reviews, (1), CD003198. PubMed · PMID 11869656
- Turner EH, et al. (2006). Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics, 109(3), 325–338. PubMed · PMID 16023217
- Das YT, et al. (2004). Safety of 5-hydroxy-L-tryptophan. Toxicology Letters, 150(1), 111–122. PubMed · PMID 15068828
- Patel YA, Marzella N. (2017). Dietary Supplement-Drug Interaction-Induced Serotonin Syndrome Progressing to Acute Compartment Syndrome. American Journal of Case Reports, 18, 926–930. PubMed · PMID 28839121
- Magnussen I, Engbaek F. (1978). The effects of aromatic amino acid decarboxylase inhibitors on plasma concentrations of 5-hydroxytryptophan in man. Acta Pharmacologica et Toxicologica, 43(1), 36–42. PubMed · PMID 309271
Link verification checks the identity of the publication; it does not constitute independent expert review of clinical claims. Our evidence and source methodology · Source directory
Frequently Asked Questions
5-HTP is a serotonin precursor. Human evidence for mood, sleep and appetite is limited; it carries a serious interaction risk with serotonergic medicines.
A standard dose of 5-HTP with established safety and effectiveness for sleep or depression has not been determined.
Long-term safety of 5-HTP has not been adequately studied; a “reasonable dose” does not establish safety. Nausea and other digestive symptoms may occur. A possible link with eosinophilia-myalgia syndrome (EMS), including the role of impurities, remains unresolved; product testing cannot guarantee clinical safety. Combining it with serotonergic medicines can cause life-threatening serotonin syndrome.
Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.
No established timeframe